Isosceles Pharmaceuticals

About:

Isosceles Pharmaceuticals is a preclinical stage biotech company that is working on perioperative acute pain product candidates.

Website: https://isoscelespharma.com/

Top Investors: Equifund

Description:

Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.

Total Funding Amount:

$5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wilmington, North Carolina, United States

Founded Date:

2019-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-10-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai